FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer August 8, 2016December 14, 2022 Alexandra Mulvey
Cancer Research Institute Featured in New York Times Cover Story on Cancer Immunotherapy August 1, 2016December 14, 2022 Brian Brewer
LabAnswer and Its Employees Raise More Than $50,000 for CRI July 29, 2016December 14, 2022 Katherine McCluskey